Invention Grant
US08809291B2 Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
有权
Id-1基因和基因产物作为治疗乳腺癌和其他类型癌症的治疗靶点
- Patent Title: Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
- Patent Title (中): Id-1基因和基因产物作为治疗乳腺癌和其他类型癌症的治疗靶点
-
Application No.: US13252148Application Date: 2011-10-03
-
Publication No.: US08809291B2Publication Date: 2014-08-19
- Inventor: Pierre-Yves Desprez , Judith Campisi
- Applicant: Pierre-Yves Desprez , Judith Campisi
- Applicant Address: US CA San Francisco US CA Oakland
- Assignee: California Pacific Medical Center Research Institute,The Regents of the University of California
- Current Assignee: California Pacific Medical Center Research Institute,The Regents of the University of California
- Current Assignee Address: US CA San Francisco US CA Oakland
- Agency: Gavrilovich, Dodd & Lindsey LLP
- Main IPC: A61K48/00
- IPC: A61K48/00 ; G01N33/574 ; C12Q1/68
Abstract:
A method for treatment of breast cancer and other types of cancer. The method comprises targeting and modulating Id-1 gene expression, if any, for the Id-1 gene, or gene products in breast or other epithelial cancers in a patient by delivering products that modulate Id-1 gene expression. When expressed, Id-1 gene is a prognostic indicator that cancer cells are invasive and metastatic.
Public/Granted literature
Information query
